https://biotechmorning.com/news/biotech-vcs-identity-crisis Biotech Morning en 2026-04-10T14:14:27.562Z Biotech VCs Are Having an Identity Crisis https://biotechmorning.com/news/car-t-three-autoimmune-diseases-remission Biotech Morning en 2026-04-10T14:13:39.823Z One Patient. Three Autoimmune Diseases. All in Remission. https://biotechmorning.com/news/rfk-jr-peptides-vaccines-contradiction Biotech Morning en 2026-04-10T14:12:54.759Z America's Health Secretary Injects Unproven Peptides (But Wants More Vaccine Research) https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-therapy Biotech Morning en 2026-04-10T14:12:12.315Z This Biotech Wants to Turn Lung Medicine Into a 10-Minute Breathing Session https://biotechmorning.com/news/why-pharma-still-cant-crack-menopause Biotech Morning en 2026-04-10T14:11:29.630Z Why Pharma Still Can't Crack Menopause (and It's Not for Lack of Trying) https://biotechmorning.com/news/oricell-110m-car-t-liver-cancer-ipo Biotech Morning en 2026-04-10T14:10:40.648Z The CAR-T Startup Betting $110M It Can Crack Liver Cancer https://biotechmorning.com/news/biotech-next-gold-rush-lpa-inhibitors Biotech Morning en 2026-04-10T14:09:58.411Z Biotech's Next Gold Rush Isn't Where You Think It Is https://biotechmorning.com/news/gut-bacteria-sugars-als-brain-damage Biotech Morning en 2026-04-10T14:09:09.572Z Your Gut Bacteria Might Be Giving Your Brain ALS https://biotechmorning.com/news/life-biosciences-80m-epigenetic-reprogramming-glaucoma Biotech Morning en 2026-04-09T14:14:04.790Z The $80M Bet That You Can Turn Back Time Inside Your Eyes https://biotechmorning.com/news/vivtex-novo-nordisk-2-billion-deal Biotech Morning en 2026-04-09T14:13:19.743Z The MIT Spinout That Just Landed a $2.1B Bet From Novo Nordisk https://biotechmorning.com/news/roche-biggest-gpu-pharma-supercomputer Biotech Morning en 2026-04-09T14:12:33.725Z Roche Just Built Pharma's Biggest Supercomputer. Here's Why. https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-therapies Biotech Morning en 2026-04-09T14:11:55.595Z Avalyn Pharma Wants to Breathe New Life Into the IPO Market https://biotechmorning.com/news/akari-wuxi-adc-deal-geopolitical-risk Biotech Morning en 2026-04-09T14:11:09.439Z The Biotech That Walked Right Into a Geopolitical Minefield https://biotechmorning.com/news/shionogi-barda-us-antibiotic-manufacturing Biotech Morning en 2026-04-09T14:10:23.397Z Why the U.S. Government Is Paying a Japanese Company to Make Antibiotics in America https://biotechmorning.com/news/roche-c4t-protein-degradation-deal Biotech Morning en 2026-04-09T14:09:34.083Z Roche Just Took a $1 Billion 'Leap of Faith' on a Cancer-Killing Trick https://biotechmorning.com/news/gilead-45m-kymera-protein-degrader-deal Biotech Morning en 2026-04-09T14:08:50.072Z Gilead's $45M Bet on a Drug That Destroys Cancer Proteins https://biotechmorning.com/news/novo-wegovy-price-war-obesity Biotech Morning en 2026-04-09T14:08:05.861Z Novo Just Started a Price War That Could Change How America Loses Weight